Adjuvant trastuzumab emtansine vs paclitaxel and trastuzumab for HER2-positive breast cancer ecancer 5:46 4 years ago 2 662 Далее Скачать
Ado-trastuzumab emtansine in patients with HER2 mutant lung cancers ecancer 6:59 7 years ago 1 622 Далее Скачать
Treatment strategies for HER2+ metastatic breast cancer VJOncology 2:15 3 years ago 242 Далее Скачать
Dr. Louis Weiner on the T-DM1 Mechanism of Action in HER2-Positive Breast Cancer OncLive 0:57 12 years ago 759 Далее Скачать
Improved IDFS for breast cancer patients who received trastuzumab emtansine ecancer 6:37 6 years ago 256 Далее Скачать
Development of antibody-drug conjugate therapies in breast cancer VJOncology 1:11 1 year ago 153 Далее Скачать
Treatment de-escalation and escalation strategies in HER2-positive breast cancer VJOncology 1:24 2 months ago 45 Далее Скачать
Kadcyla ( T-DM1 ) an Amazing New Breast Cancer Drug Oncology Associates 3:21 11 years ago 16 121 Далее Скачать
Current Treatment Options for Patients With HER2-Positive Metastatic Breast Cancer Targeted Oncology 1:31 5 years ago 3 164 Далее Скачать
PHranceSCa: evaluating patient satisfaction with subcutaneous pertuzumab and trastuzumab treatment VJOncology 2:06 4 years ago 480 Далее Скачать
Dr. Tripathy on Determining the Best HER2 Targeted Therapy OncLive 1:06 13 years ago 161 Далее Скачать
Trastuzumab deruxtecan shows benefit across HER2+ metastatic breast cancer subgroups ecancer 5:09 2 years ago 1 050 Далее Скачать
Trastuzumab deruxtecan vs trastuzumab emtansine in patients with HER2+ metastatic breast cancer ecancer 12:47 3 years ago 919 Далее Скачать
#ESMO21 Expert Video Report on HER2-positive metastatic breast cancer European Society for Medical Oncology (ESMO) 7:30 3 years ago 1 414 Далее Скачать
HER2+ Breast Cancer: Evolution of Antibody-Drug Conjugates OncLive 3:36 4 years ago 252 Далее Скачать
Dr. Vidal on Potential of [Fam-] Trastuzumab Deruxtecan in HER2+ Breast Cancer OncLive 1:31 5 years ago 574 Далее Скачать
